[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"fda-events-search:[\"\",\"\",\"NCD\",\"1990-01-01\",\"2026-11-17\",1]":3,"fda-latest-sync-dates":26},{"events":4,"total":25},[5],{"mdr_report_key":6,"report_number":6,"event_type":7,"date_received":8,"date_of_event":9,"report_source_code":10,"adverse_event_flag":11,"product_problem_flag":12,"product_problems":13,"brand_name":15,"generic_name":16,"product_code":17,"manufacturer_name":18,"model_number":19,"patient_outcomes":20,"remedial_action":22,"created_at":24,"updated_at":24},"23389720","Malfunction","2025-10-27","2025-10-01","User Facility report","N","Y",[14],"Failure to Obtain Sample","QUANTIFERON®-TB GOLD PLUS","TEST, IMMUNITY, CELL MEDIATED, MYCOBACTERIUM TUBERCULOSIS","NCD","QIAGEN SCIENCES LLC","1",[21],"Other",[23],"","2026-07-15T12:18:44.511722+00:00",1,{"510k":27,"classification":28,"enforcement":29,"event":30,"event_backfill":31,"pma":32,"warning_letter":33},"2026-11-16T02:00:55.89+00:00","2026-11-16T02:00:41.999+00:00","2026-11-16T02:00:49.415+00:00","2026-11-17T04:00:34.414+00:00","2026-09-07T05:17:28.839+00:00","2026-11-16T02:01:03.155+00:00","2026-11-17T01:02:55.859+00:00"]